Sign In
Buy SGHT
$4.34
+0 (+0%)
At Close: Jun 03, 2026
Sight Sciences (SGHT) to Expand in Europe With New Launch
11:26am, Wednesday, 21'st Feb 2024
By tapping into the European market, Sight Sciences (SGHT) aims to capitalize on the growing demand for advanced eye care technologies.
Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting
04:05pm, Wednesday, 14'th Feb 2024
MENLO PARK, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing i
Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital
04:05pm, Tuesday, 23'rd Jan 2024
MENLO PARK, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences”), an eyecare technology company focused on developing and commercializing innovative tec
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
04:05pm, Monday, 08'th Jan 2024
MENLO PARK, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing i
Sight Sciences Announces Withdrawal of Final LCDs on Micro-Invasive Glaucoma Surgery from Five Medicare Administrative Contractors
09:15am, Thursday, 28'th Dec 2023
Decision ensures continued access to comprehensive outflow procedure enabled by OMNI® Surgical System technology for glaucoma patients Decision ensures continued access to comprehensive outflow proce
Interventional eyelid procedures enabled by TearCare technology successfully delivered clinically and statistically significant improvements in every sign and symptom measured at every time point thro
Prospective, long-term trial results are consistent with the significant body of published clinical evidence demonstrating the durable safety and effectiveness of procedures enabled with the OMNI Surg
5 Risky Stocks to Buy Immediately, According to AI
03:40pm, Monday, 13'th Nov 2023
This article is an excerpt from the InvestorPlace Digest newsletter. To get news like this delivered straight to your inbox, click here.
Sight Sciences, Inc. (SGHT) Q3 2023 Earnings Call Transcript
12:38pm, Saturday, 11'th Nov 2023
Sight Sciences, Inc. (NASDAQ:SGHT ) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Philip Taylor - Investor Relations, Gilmartin Group Paul Badawi - Founder and Chie
Sight Sciences to Report Third Quarter 2023 Financial Results on November 7, 2023
04:05pm, Tuesday, 24'th Oct 2023
MENLO PARK, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commerci
Top 4 Health Care Stocks That Could Lead To Your Biggest Gains In Q3 - Sight Sciences (NASDAQ:SGHT), Scilex Holding (NASDAQ:SCLX)
05:11am, Thursday, 21'st Sep 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Sight Sciences' stock tumbled 32% premarket after revenue warning
07:04am, Tuesday, 12'th Sep 2023
Sight Sciences Inc.'s stock SGHT, +6.03% tumbled 32% premarket Tuesday, after the eyecare technology company issued a revenue warning, saying it's seen fewer Surgical Glaucoma new accounts in the thir
Sight Sciences to Present at the Upcoming Morgan Stanley 21st Annual Global Healthcare Conference
04:05pm, Wednesday, 30'th Aug 2023
MENLO PARK, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commerci
Sight Sciences: Staying Bullish After Q2 Results Beat
02:00pm, Monday, 07'th Aug 2023
Sight Sciences' Q2 2023 financial performance came in above Wall Street analysts, and SGHT's stock price rose by +7.6% last Friday following its results announcement. SGHT's key markets, glaucoma and
Sight Sciences, Inc. (SGHT) Q2 2023 Earnings Call Transcript
07:32am, Sunday, 06'th Aug 2023
Sight Sciences, Inc. (NASDAQ:SGHT ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Philip Tailor - Investor Relations Paul Badawi - Co-Founder & Chief Executive Office
